Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
IPO Update: Mid-Year Average Return Deceptively Positive In Down Market
Outlier Leads To 25% Gain For 2022 Offerings
Jul 06 2022
•
By
Mandy Jackson
Excluding the top two performers, the average return dropped from 25% to -33% • Source: Shutterstock
More from Financing
More from Business